PaxMedica Inc. Common Sto... (PXMD)
PaxMedica Common Stock Statistics
Share Statistics
PaxMedica Common Stock has 10.88M shares outstanding. The number of shares has increased by 46.86% in one year.
| Shares Outstanding | 10.88M |
| Shares Change (YoY) | 46.86% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 2.02% |
| Shares Floating | 10.36M |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 637.72K, so 5.86% of the outstanding shares have been sold short.
| Short Interest | 637.72K |
| Short % of Shares Out | 5.86% |
| Short % of Float | 6.15% |
| Short Ratio (days to cover) | 0.1 |
Valuation Ratios
The PE ratio is -0.07 and the forward PE ratio is -0.03. PaxMedica Common Stock's PEG ratio is 0.
| PE Ratio | -0.07 |
| Forward PE | -0.03 |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 0.37 |
| P/FCF Ratio | -0.12 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for PaxMedica Inc. Common Stock.
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.16, with a Debt / Equity ratio of 0.
| Current Ratio | 3.16 |
| Quick Ratio | 3.16 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | -1761.62 |
Financial Efficiency
Return on equity (ROE) is -5.4% and return on capital (ROIC) is -476.95%.
| Return on Equity (ROE) | -5.4% |
| Return on Assets (ROA) | -3.22% |
| Return on Capital (ROIC) | -476.95% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -3.05M |
| Employee Count | 6 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is -0.56, so PaxMedica Common Stock's price volatility has been lower than the market average.
| Beta | -0.56 |
| 52-Week Price Change | null% |
| 50-Day Moving Average | 0.04 |
| 200-Day Moving Average | 0.14 |
| Relative Strength Index (RSI) | 37.02 |
| Average Volume (20 Days) | - |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -16.15M |
| Net Income | -18.29M |
| EBITDA | -16.15M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -11 |
Balance Sheet
The company has 4.71M in cash and 0 in debt, giving a net cash position of 4.71M.
| Cash & Cash Equivalents | 4.71M |
| Total Debt | 0 |
| Net Cash | 4.71M |
| Retained Earnings | -52.03M |
| Total Assets | 799.61K |
| Working Capital | -1.31M |
Cash Flow
In the last 12 months, operating cash flow was -10.77M and capital expenditures 0, giving a free cash flow of -10.77M.
| Operating Cash Flow | -10.77M |
| Capital Expenditures | 0 |
| Free Cash Flow | -10.77M |
| FCF Per Share | -6.48 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PXMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for PXMD.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Oct 31, 2023. It was a backward split with a ratio of 1:17.
| Last Split Date | Oct 31, 2023 |
| Split Type | backward |
| Split Ratio | 1:17 |
Scores
| Altman Z-Score | -167.52 |
| Piotroski F-Score | 2 |